Volume 30, Issue 139 (March & April 2022)                   J Adv Med Biomed Res 2022, 30(139): 170-176 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Davoudimoghadam N, Daneshmand F, Azhdari M. Vitamin C Ameliorates Acrylamide-Induced Nephrotoxicity and Improves the Biochemical Parameters in Rats. J Adv Med Biomed Res 2022; 30 (139) :170-176
URL: http://journal.zums.ac.ir/article-1-6414-en.html
1- Dept. of Biology, Payame Noor University, Yazd, Iran
2- Dept. of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , azhdari_mar@yahoo.com
Full-Text [PDF 543 kb]   (48585 Downloads)     |   Abstract (HTML)  (94366 Views)

✅ The present study showed that chronic consumption of acrylamide can lead to pathological changes in kidney tissue as well as unfavorable alternation in serum urea, creatinine, TAC, and MDA levels. Concurrent vitamin C consumption had a significant preventive effect on the aforementioned parameters. Therefore, vitamin C can play a protective and antioxidant role in decreasing the toxic effects of acrylamide in rat kidneys. 


Full-Text:   (1648 Views)
Introduction
 

Acrylamide (2-propenamide), an odorless white crystalline substance, was discovered in in Germany in 1893 by Moureu. Acrylamide has a melting point of 84.5 °C that is stable at room temperature, it is rapidly polymerized upon melting (1). Acrylamide is present in highly- heated foods such as fried potatoes, spaghetti, and bread (2). Exposure to acrylamide occurs mainly through oral intake, skin contact, and inhalation. The main mechanism for acrylamide formation in foods is related to the Millard reaction (3).
After consumption, monomers of acrylamide are easily absorbed from the digestive tract, enter the blood circulation, spread to different organs, react with hemoglobin, DNA, and some cellular enzymes, and produce various toxic effects (4). It can pass through the placenta and be transmitted to the fetus (5). Glomerular changes, infiltration of inflammatory cells, and degenerative vascular changes have been observed in the kidney which is the main organ eliminating acrylamide and its metabolites (6). Acrylamide induces oxidative stress, resulting in the generation of reactive oxygen species (ROS) (7) which play a critical role in the initiation and progression of fibrotic diseases (8) and can damage some organs and tissues such as the liver and kidney (2, 4, 8-10).
The antioxidant system confronts the damage resulted from free radicals via preventing the formation of free radicals, restoring the damages caused by radicals, increasing the excretion of damaged molecules, and minimizing cellular mutation. Enzymatic antioxidant defense systems include superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase, and non-enzymatic substances including antioxidant compounds in foods (e.g. vitamins E, C, and A) (11). Vitamin C or ascorbic acid is necessary for growth, development and the normal functioning of all cells including collagen biosynthesis, immune system, and wound healing due to the presence of the antioxidant properties (12). In addition to scavenging the free radicals, vitamin C causes the re-entry of other antioxidants such as vitamin E and urate into the cycle.
In recent years, much attention has been paid to the presence of acrylamide in foods. The increasing human exposure to acrylamide has led the researchers to study the harmful effects of acrylamide intake as well as the use of the antioxidants in order to prevent oxidative tissue damage. The present study aimed to evaluate the effect of vitamin C on the biochemical parameters and histological changes in the kidney tissue damage induced by acrylamide in rats.

 

 

Materials and Methods

Animals
The present experimental study was carried out on 40 male rats which were kept from birth under standard conditions (free access to food and water, the controlled temperature at 21 ± 3 °C, and 12 hours of light/12 hours of darkness) in the animal house of Shahid Sadoughi University of medical sciences in Yazd, Iran.
Animal Ethics
All ethical principles of laboratory animal procedures were in accordance with those approved by the Ethics Committee of Payame Noor University (Ethics committee code: IR.PNU.REC.1397.042).
Experimental Design
Forty rats were randomly divided into four groups with 10 rats in each group. The first group received distilled water (normal group), daily, the second group received 20 mg/kg/day acrylamide (Merck, Germany) (AA group) (8, 13, 14), the third group received 200 mg/kg/day vitamin C (Darupakhsh Co., Iran) (vitamin C group)(15) and the fourth group received 20 mg/kg/day acrylamide plus 200 mg/kg vitamin C (AA + vitamin C group). The animals weighing 60-80 g were fed by the oral gavage from infancy for 2 months at a specific hour. Six hours after receiving the last dose of treatments, the animals were generally anesthetized via intraperitoneal injection of xylazine 5 mg/kg plus ketamine 50 mg/kg (Alfasan Co, The Netherlands), and the blood samples were taken from the right atrium for biochemical tests. The biochemical and antioxidant assessments were carried out in duplicate. The kidney was also removed and placed in buffered 10% formalin fixative for evaluation of histologic changes. The assessors, involved in the biochemical, antioxidant, and histological assessment were blinded to the treatment allocation.
Biochemical and Antioxidant Tests
  Serum levels of urea and creatinine were measured using enzymatic and Jaffe method by commercial kits (Man Company, Iran), respectively.
 The reaction with thiobarbituric acid (TBA) is the basis for malondialdehyde measurement (16). MDA reacts with TBA and the resulting red color has the highest light absorbance at 532 nm. In brief, 0.1 mL of serum was mixed with 0.375 mL of 20% acetic acid and 0.375 mL of 0.6% TBA solution which was heated for 60 minutes in a boiling water bath. The solution was then placed in the cold water for 10 minutes, to which 1.25 mL of normal butanal/pyridine with 1:15 ratio was added and then centrifuged for 5 minutes at about 2000 rpm. Then, the butanal phase absorption was assayed at 532 nm. The MDA concentration was reported in µmol/mL (7).
Total antioxidant capacity (TAC) was estimated via the reduction of diphenyl-picrylhydrazyl (DPPH). To do this, 0.0039 g of DPPH powder was mixed with 10 mL of methanol, the solution was mixed by a vortex, and 1 mL of it was added to 9 mL of methanol. Then 20 µL of sample and 380 μL of phosphate buffer (pH=7.4) were mixed with 400 μL of DPPH methanol solution by a vortex. The solution was incubated for half an hour at room temperature. Then, 100 μL of the working solution was added to the 96-well microplate and then measured at 520 nm by enzyme-linked immunosorbent assay (ELISA) reader. The concentration of DPPH scavenging capacity was calculated according to the following formula (7):
DPPH reduced (%) = [(A-Ax)/ Ax] × 100
A = Absorbance of (DPPH + plasma), Ax = Absorbance of (DPPH + methanol as blank))
Histological Preparation and Techniques
An assessor who was blinded to the allocation selected the 5 rats in each group for histologic measurement, randomly. The kidneys of rats were fixed by the formalin solution and sectioned and passed through the tissue processor (Lipshaw Model 2500, US) followed by paraffin embedding (Did Sabz paraffin dispenser, model DS-4LM, Iran). Three sections of 5-7- micrometer- thickness were made for each specimen by a microtome (Leitz 1512, Germany) (17). Hematoxylin and eosin-stained (H&E) slides were imaged (Olympus, model CH-30, Japan) and studied by a blinded pathologist.
Statistical Analysis
The comparison of the biochemical parameters was analyzed using one-way ANOVA with Tukey post-test, and shown as mean ± standard deviation (SD). SPSS statistical software package, version 16.0 (SPSS, Inc, Chicago, Illinois, USA), was applied for statistical analyses. The significance level was considered at P ≤ 0.05.

 
 
Results

The biochemical parameters were shown in Table 1 and figure S.1-4 (supplementary file). The mean serum urea (mg/dL) demonstrated a significant increase in the AA group compared to the normal group (48.1 ± 1.2 vs. 38 ± 0.6, P ≤ 0.001). The mean serum urea in the vitamin C group was significantly lower than the AA group (35.5 ± 1.1 vs. 48.1 ± 1.2, P ≤ 0.001). In the AA + vitamin C group, serum urea was significantly lower than the AA group (38.6 ± 0.9 vs. 48.1 ± 1.2, P ≤ 0.001). Furthermore, no significant difference was found between the vitamin C, AA + vitamin C, and normal groups (P > 0.05) (Figure S.1. supplementary file).
The mean serum creatinine levels (mg/dL) were significantly higher in the AA group compared to the normal group (1.5 ± 0.1 vs. 0.7 ± 0.04, P ≤ 0.001).  A decrease in serum creatinine levels was found in the AA + vitamin C group (0.9 ± 0.04) and the vitamin C group (0.7 ± 0.04) compared to the AA group (1.5 ± 0.1), (P < 0.001).  There was no significant difference between the AA + vitamin C, normal, and vitamin C groups (P > 0.05) (Figure S.2. supplementary file).
The results of the serum TAC (%) as a marker of antioxidant capacity were revealed in Table 1. A significant reduction was found in the AA group in comparison with the normal group (25.81 ± 2.3 vs. 46.78 ± 2.3, P ≤ 0.001). In comparison to the AA group, the AA + vitamin C group had no significant enhancement (34.46 ± 3.03 vs. 25.81 ± 2.3, P = 0.14). In addition, the serum TAC (%) in the vitamin C group was significantly higher than the AA (54.52 ± 3.2 vs. 25.81 ± 2.3) and the AA + vitamin C groups, (P ≤ 0.001). Moreover, there was no significant difference between the vitamin C and normal groups (P= 0.21) (Figure S.3. supplementary file).
MDA (µmol/mL), as a marker of oxidative stress and lipid peroxidation, was markedly higher in the AA group compared to all other groups (P ≤ 0.001). A significant increase was observed in the AA group compared with both the normal (0.3 ± 0.04 vs. 0.16 ± 0.007, P = 0.002) and the AA + vitamin C group (0.3 ± 0.04 vs. 0.18 ± 0.034, P = 0.004). The vitamin C group revealed a significant decrease in MDA compared to the AA group (0.09 ± 0.005 vs. 0.3 ± 0.04, P ≤ 0.001). There were no significant differences between other groups (P > 0.05) (Figure S.4. supplementary file).
 

Table 1. The comparison of the biochemical parameters between four groups.

Biochemistry parameters Group p-value
Normal
(n=10)
Acrylamide
(n=10)
Vitamin C
(n=10)
Acrylamide+ Vitamin C
(n=10)
Urea (mg/dL) 38 ± 0.6a 48.1 ± 1.2a,b,c 35.5 ± 1.1b 38.6 ± 0.9c ≤ 0.001
Creatinine (mg/dL) 0.7 ± 0.04a 1.5 ± 0.1a,b,c 0.7 ± 0.04b 0.9 ± 0.04c ≤ 0.001
TAC (%) 46.78 ± 2.3a 25.81 ± 2.3a,b 54.52 ± 3.2b,c 34.46 ± 3.03c ≤ 0.001
MDA (µmol/mL) 0.16 ± 0.007a 0.3 ± 0.04a,b,c 0.09 ± 0.005b 0.18 ± 0.034c ≤ 0.001

MDA: malondialdehyde; TAC: Total antioxidant capacity.
Data were presented as mean ± standard deviation.
P-value was calculated for the comparison variables between four groups using one-way analysis of variance (one-way ANOVA).
a Pairwise comparisons were performed by post hoc (LSD) analysis.

 
The renal histological assessment was depicted in Figure 1.A to D. As projected in Figure 1.A, in the normal, AA, AA + Vitamin C, and Vitamin C groups, respectively. No clear pathologic finding was observed in the normal group. There were normal glomeruli (green arrow) and tubules (blue arrow) in the normal group (Figure 1. A). The renal tissue changes in the AA group was represented in Figure 1.B. the glomerular degeneration/atrophy (green arrows), the expansion of Bowman's capsule (asterisk), and the destruction of the epithelial cells were observed in the convoluted tubules (blue arrows). The numbers of glomeruli which were counted under high power fields (400X), were lower than those of the other groups. Moreover, hyperemia was observed in the renal vessels (yellow arrow). The proximal and distal-tubular necrosis and inflammation and infiltration of inflammatory cells were seen in the kidney cortex. In addition, the thickening and fibrosis of the kidney capsule were found in the AA group. In the AA + vitamin C group, the degenerative changes were less than the AA group (Figure 1.C). The glomeruli (green arrow) were larger than those in the AA group, and the proximal-tubular degeneration was not observed (blue arrow). Figure 1.D showed the histological assessment in the vitamin C group. Although the normal glomeruli (green arrow) without inflammation were observed in the interstitial tissue (blue arrow) in the vitamin C group, mild hyperemia was depicted in the renal parenchyma (yellow arrow).
 

Figure 1. Histological examination of the kidney (400 ×, H&E staining) in the studied groups. A: The normal group with the normal glomeruli and tubules (green and blue arrow, respectively). B: The acrylamide group with the glomerular degeneration (green arrows), expansion of Bowman's capsule (asterisk), and  the epithelial cell destruction in convoluted tubules (blue arrows). C: The acrylamide + Vitamin C group with the glomeruli (green arrow) and proximal tubular (blue arrow). D: The vitamin C group with the normal glomeruli (green arrow), and normal interstitial tissue (blue arrow), mild hyperemia in the renal parenchyma (yellow arrow). H&E: Hematoxylin & Eosin staining. 

Figure 1. Histological examination of the kidney (400 ×, H&E staining) in the studied groups. A: The normal group with the normal glomeruli and tubules (green and blue arrow, respectively). B: The acrylamide group with the glomerular degeneration (green arrows), expansion of Bowman's capsule (asterisk), and  the epithelial cell destruction in convoluted tubules (blue arrows). C: The acrylamide + Vitamin C group with the glomeruli (green arrow) and proximal tubular (blue arrow). D: The vitamin C group with the normal glomeruli (green arrow), and normal interstitial tissue (blue arrow), mild hyperemia in the renal parenchyma (yellow arrow). H&E: Hematoxylin & Eosin staining.

 
 

Discussion

The findings of the present study showed a significant increase in serum urea, creatinine, and MDA levels in the AA group compared to the other groups with no remarkable difference between the normal, vitamin C, and AA + vitamin C groups. The serum TAC levels showed a clear increase in the vitamin C and normal groups compared to AA and AA + vitamin C groups. Serum MDA levels were significantly lower in the vitamin C group than the other groups. The evaluation of the renal tissue changes showed a considerable difference between the control group with the other groups. In the AA + vitamin C group, pathological changes were lower in comparison with the AA group, which can justify the protective and antioxidant role of vitamin C in preventing the toxic effects of acrylamide. There was no report on the adverse effects on the kidney function. Based on a comprehensive review of the literature (8, 13-15), the dose of vitamin C or acrylamide which was selected caused no severe adverse effects.
Acrylamide can cause the renal and hepatic tissue damage (8, 10, 18-20), the unfavorable alterations on serum urea and creatinine levels in rats (8, 18). The protective effects of vitamin E in acrylamide-induced renal toxicity in rats had been addressed in the study by Ated et al (8). A significant decrease in the serum creatinine and urea levels was shown in the acrylamide and vitamin E groups compared to the acrylamide group which is similar to our study on the protective effect of vitamin C (8). Salman et al., (2020) showed  that oral ascorbic acid can improve acrylamide- induced hepatotoxicity in  rats (20). The results of another study (2011) showed that the treatment with natural products containing cocoa in human cell cultures can decrease acrylamide-induced ROS production and prevent apoptosis (21). Acrylamide exposure in the animals resulted in the DNA damage, inflammation, necrosis, and apoptosis in the liver (4).
Moreover, Mahmood et al.,(2015) (10) investigated the effects of different doses of acrylamide in Wistar rats. In support of the findings of our study, Mahmood et al., showed more degenerative changes at doses of 10 and 30 mg of acrylamide per kg (mg/kg) than 2 mg/kg on the kidney and liver tissue. They found no significant difference between serum urea and creatinine levels in the acrylamide group (with a daily dose of 2 mg/kg of body weight) in comparison with the normal group (receiving distilled water). Contrary to expectations, they illustrated a significant decrease in serum urea and creatinine levels in rats that received doses of 10 (moderate dose) or 30 (high dose) mg/kg of body weight from the normal group. Their results were in contrast with the findings of the present study and other studies (8, 18). However, they reported that a moderate or high dose leads to a decrease of about 25 % of nephron function, and for the changes in serum levels, the function of nephrons should reach less than 30% (10), but it seems that there is  no scientific justification for lowering serum urea and creatinine levels.
The deleterious effects of acrylamide were addressed on histological changes, blood and enzyme parameters in rats. The researchers found that acrylamide can decrease serum antioxidants (serum vitamin C), increase MDA, and also cause histopathological alterations in the kidney (22).
 Alturfan et al., showed that resveratrol as an antioxidant could promote the enhanced MDA levels, reduce GSH levels, and oxidative stress damage in the kidney induced by acrylamide. They suggested that the resveratrol supplementation can be useful for reducing acrylamide toxicity (23).
 Moreover, Rajeh et al., found that the combined administration of vitamin E and 5-aminosalicylic acid reversed the toxic effects of acrylamide on renal tubules (19). The protective effect of vitamin E on acrylamide-induced liver tissue damages was shown by Siahkoohi (24). His findings for the different antioxidants (vitamin E and 5-Aminosalicylic acid co-supplementation, resveratrol, vitamin E, and cocoa) (19, 21, 23, 24) were similar to the present results for vitamin C.
However, the oxidative stress which can lead to an imbalance in antioxidant capacity may be considered as the main factor for deleterious effects of acrylamide (25). Acrylamide may exert its effects by binding the sulfhydryl groups to the proteins and enzymes resulting in DNA repair and cell dysfunction (26), decreasing the antioxidant storages, mitochondrial dysfunction, increasing the inflammatory markers (interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α)), and apoptosis (21, 27) by increasing caspase-3 (27) that leads to toxicity in the nerve system (1), and dysfunction of the liver (4, 10, 18), kidney (18, 22, 23), and reproductive process, and the carcinogenic effects on different organs (1, 25, 27).
To date, the effects of vitamin C have not been evaluated on acrylamide-induced nephrotoxicity. On the other hand, several mechanisms have illustrated the protective effects of other antioxidants regardless of antioxidant power including blocking acrylamide formation emanating from the increasing or decreasing reaction between the substrates in the Maillard reaction (28), scavenging free radical activity (28, 29), neurogenerative activities, detoxification, inhibition of MAO activity, and acetyl-cholinesterase (27). It is noteworthy that some antioxidants with weak activity such as naringenin (30) can be more effective than the potent antioxidants including curcumin (31).
The strengths of the present study were 1) the long-term follow-up (2 months) of acrylamide-induced toxicity at the moderate dose and the protective effect of vitamin C in rats while the duration of similar previous studies were 5 (19), 10 (23), and 35 days (24); and 2) the large sample size in comparison to other studies (19, 23, 24).
The main limitation of this study and some others (8, 13, 14) was the use of a single-dose acrylamide and vitamin C.


 

Conclusion

In conclusion, the present study showed that chronic consumption of acrylamide can lead to renal dysfunction as indicated by the elevated serum urea and creatinine levels, as well as imbalance in serum antioxidant (TAC) and oxidation (MDA) levels. Concurrent vitamin C consumption had a significant preventive effect on the aforementioned parameters, in addition to the prevention of renal tissue degeneration. It seems to be necessary to design the studies with the prescription of different doses of vitamin C and acrylamide and also, the evaluation of the molecular and cellular mechanisms of vitamin C against acrylamide.

 

Acknowledgements

The authors sincerely thank Dr. Hekmatimoghadam and Zavarreza for their cooperation in this study. All ethical principles of laboratory animal procedures were in accordance with those approved by the Ethics Committee of Payame Noor University (Ethics committee code: IR.PNU.REC.1397.042).

 

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

 

Conflicts of Interest

The authors declare no competing interest.


 

Type of Study: Original Research Article | Subject: Clinical Medicine
Received: 2021/01/31 | Accepted: 2021/05/4 | Published: 2022/01/31

References
1. Besaratinia A, Pfeifer GP. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis. 2007;28(3):519-28. [DOI:10.1093/carcin/bgm006] [PMID]
2. Kermani-Alghoraishi M, Anvari M, Talebi AR, Amini-Rad O, Ghahramani R, Miresmaili SM. The effects of acrylamide on sperm parameters and membrane integrity of epididymal spermatozoa in mice. Europe J Obstet Gynecol Reproduct Biol. 2010;153(1):52-5. [DOI:10.1016/j.ejogrb.2010.07.008] [PMID]
3. Taeymans D, Wood J, Ashby P, et al. A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr. 2004;44(5):323-47. [DOI:10.1080/10408690490478082] [PMID]
4. Sabik L, Moustafa GG, Sharkawi NI, Sabik LM. Acrylamide-induced genotoxic, biochemical and pathological perturbations in male rats liver. J Am Sci. 2011;7(1):1092-6.
5. Lai Sm, Gu Zt, Zhao Mm, et al. Toxic effect of acrylamide on the development of hippocampal neurons of weaning rats. Neural Regenerat Res. 2017;12(10):1648. [DOI:10.4103/1673-5374.217345] [PMID] [PMCID]
6. Eman M, Amany Y. Some studies on acrylamide intoxication in male albino rats. Egypt J Compar Pathol Clin Pathol. 2008;21(4).
7. Teodor V, Cuciureanu M, Filip C, Zamosteanu N, Cuciureanu R. Protective effects of selenium on acrylamide toxicity in the liver of the rat. Effects on the oxidative stress. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2011;115(2):612-8.
8. Atef H, Attia GM, Rezk HM, El-Shafey M. Effect of vitamin E on biochemical and ultrastructural changes in acrylamide-induced renal toxicity in rats. Int J Sci Report. 2017;3(5):134-43. [DOI:10.18203/issn.2454-2156.IntJSciRep20171999]
9. Tozan-Beceren A, Sehirli AO, Eksioglu-Demiralp E, Sener G, Omurtag GZ. Melatonin protects against acrylamideinduced oxidative tissue damage in rats. Marmara Pharmaceut J. 2012;16(3):213-21. [DOI:10.12991/201216401]
10. Mahmood SA, Amin KA, Salih SF. Effect of acrylamide on liver and kidneys in albino wistar rats. Int J Curr Microbiol App Sci. 2015;4(5):434-44.
11. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Org J. 2012;5(1):9-19. [DOI:10.1097/WOX.0b013e3182439613] [PMID] [PMCID]
12. Kim EJ, Won R, Sohn JH, et al. Anti-oxidant effect of ascorbic and dehydroascorbic acids in hippocampal slice culture. Biochem Biophysic Res Communicat. 2008;366(1):8-14. [DOI:10.1016/j.bbrc.2007.11.050] [PMID]
13. Rahangadale S, Kurkure N, Prajapati B, Hedaoo V, Bhandarkar AG. Neuroprotective effect of vitamin e supplementation in wistar rat treated with acrylamide. Toxicol Int. 2012;19(1):1. [DOI:10.4103/0971-6580.94505] [PMID] [PMCID]
14. Rahangadale S, Jangir BL, Patil M, et al. Evaluation of protective effect of vitamin e on acrylamide induced testicular toxicity in wister rats. Toxicol Int. 2012;19(2):158. [DOI:10.4103/0971-6580.97216] [PMID] [PMCID]
15. Dortaj H, Yadegari M, Abad MHS, Sarcheshmeh AA, Anvari M. Stereological method for assessing the effect of vitamin C administration on the reduction of acrylamide-induced neurotoxicity. Basic Clin Neurosci. 2018;9(1):27. [DOI:10.29252/nirp.bcn.9.1.27] [PMID] [PMCID]
16. Zeb A, Ullah F. A simple spectrophotometric method for the determination of thiobarbituric acid reactive substances in fried fast foods. Journal of analytical methods in chemistry. 2016;2016. [DOI:10.1155/2016/9412767] [PMID] [PMCID]
17. Shang YM, Wang GS, Sliney D, Yang CH, Lee LL. White light-emitting diodes (LEDs) at domestic lighting levels and retinal injury in a rat model. Environ Health Perspect. 2014;122(3):269. [DOI:10.1289/ehp.1307294] [PMID] [PMCID]
18. Rivadeneyra-Domínguez E, Becerra-Contreras Y, Vázquez-Luna A, Díaz-Sobac R, Rodríguez-Landa JF. Alterations of blood chemistry, hepatic and renal function, and blood cytometry in acrylamide-treated rats. Toxicol Reports. 2018;5:1124-8. [DOI:10.1016/j.toxrep.2018.11.006] [PMID] [PMCID]
19. Rajeh NA, Al-Dhaheri NM. Antioxidant effect of vitamin E and 5-aminosalicylic acid on acrylamide induced kidney injury in rats. Saudi Medi J. 2017;38(2):132. [DOI:10.15537/smj.2017.2.16049] [PMID] [PMCID]
20. Salman A, El-Ghazouly DE-S, El Beltagy M. Role of ascorbic acid versus silymarin in amelioration of hepatotoxicity induced by acrylamide in adult male albino rats: Histological and immunohistochemical study. Int J Morphol. 2020;38(6). [DOI:10.4067/S0717-95022020000601767]
21. Rodriguez-Ramiro I, Ramos S, Bravo L, Goya L, Martin MA. Procyanidin B2 and a cocoa polyphenolic extract inhibit acrylamide-induced apoptosis in human Caco-2 cells by preventing oxidative stress and activation of JNK pathway. J Nutr Biochem. 2011;22(12):1186-94. [DOI:10.1016/j.jnutbio.2010.10.005] [PMID]
22. Ghorbel I, Elwej A, Fendri N, et al. Olive oil abrogates acrylamide induced nephrotoxicity by modulating biochemical and histological changes in rats. Renal Failure. 2017;39(1):236-45. [DOI:10.1080/0886022X.2016.1256320] [PMID] [PMCID]
23. Alturfan AA, Tozan-Beceren A, Şehirli AÖ, Demiralp E, Şener G, Omurtag GZ. Resveratrol ameliorates oxidative DNA damage and protects against acrylamide-induced oxidative stress in rats. Molec Biol Report. 2012;39(4):4589-96. [DOI:10.1007/s11033-011-1249-5] [PMID]
24. Siahkoohi S, Anvari M, Akhavan Tafti M, Hosseini-sharifabad M. The effects of vitamin E on the liver integrity of mice fed with acrylamide diet. Iran J Pathol. 2014;9(2):89-98.
25. Zamani E, Shokrzadeh M, Fallah M, Shaki F. A review of acrylamide toxicity and its mechanism. Pharmaceut Biomed Res. 2017;3(1):1-7. [DOI:10.18869/acadpub.pbr.3.1.1]
26. Exon J. A review of the toxicology of acrylamide. J Toxicol Environ Health, Part B. 2006;9(5):397-412. [DOI:10.1080/10937400600681430] [PMID]
27. Kahkeshani N, Saeidnia S, Abdollahi M. Role of antioxidants and phytochemicals on acrylamide mitigation from food and reducing its toxicity. J Food Sci Technol. 2015;52(6):3169-86. [DOI:10.1007/s13197-014-1558-5] [PMID] [PMCID]
28. Jin C, Wu X, Zhang Y. Relationship between antioxidants and acrylamide formation: A review. Food Res Int. 2013;51(2):611-20. [DOI:10.1016/j.foodres.2012.12.047]
29. Hong Y, Nan B, Wu X, Yan H, Yuan Y. Allicin alleviates acrylamide-induced oxidative stress in BRL-3A cells. Life Sci. 2019;231:116550. [DOI:10.1016/j.lfs.2019.116550] [PMID]
30. Cheng KW, Zeng X, Tang YS, et al. Inhibitory mechanism of naringenin against carcinogenic acrylamide formation and nonenzymatic browning in Maillard model reactions. Chem Res Toxicol. 2009;22(8):1483-9. [DOI:10.1021/tx9001644] [PMID]
31. Hamzalıoğlu A, Mogol BA, Lumaga RB, Fogliano V, Gökmen V. Role of curcumin in the conversion of asparagine into acrylamide during heating. Amino Acids. 2013;44(6):1419-26. [DOI:10.1007/s00726-011-1179-5] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb